Evidence map

ArticleAging2019

Rosiglitazone has a neutral effect on the risk of dementia in type 2 diabetes patients.

Chin-Hsiao TsengPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 31085804